Hong Kong’s First Listed Peptide Innovative Drug Company: Micot Pharma Innovative Pipeline Poised for Breakthrough, Clear Positioning in the Cardio-Renal-Metabolic Space
EQS via SeaPRwire.com / 25/06/2026 / 18:12 UTC+8 On 24 June, Micot Pharma-B (02335.HK) officially listed on the Hong Kong Stock Exchange, becoming the first innovative drug company under Chapter 18A of the Hong Kong Listing Rules with a peptide
More